Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19
Emilly Caroline dos Santos Moraes(Fundação Oswaldo Cruz), Monique R. O. Trugilho(Fundação Oswaldo Cruz), Thiago Moreno L. Souza(National Institute of Science and Technology), Isaclaudia G. Azevedo-Quintanilha(Fundação Oswaldo Cruz), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Hugo C. Castro‐Faria‐Neto(Fundação Oswaldo Cruz), Samuel Coelho Mandacaru(Fundação Oswaldo Cruz), Fernando A. Bozza(D’Or Institute for Research and Education), Reynaldo Magalhães Melo(Universidade de Brasília), Luana Rocha da Silva(Fundação Oswaldo Cruz), Remy Martins-Gonçalves(Fundação Oswaldo Cruz), Eugênio D. Hottz(Universidade Federal de Juiz de Fora), Jonás Perales(Fundação Oswaldo Cruz)
Cited by 23
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527